148 related articles for article (PubMed ID: 17908708)
1. The use of statins and lung function in current and former smokers.
Keddissi JI; Younis WG; Chbeir EA; Daher NN; Dernaika TA; Kinasewitz GT
Chest; 2007 Dec; 132(6):1764-71. PubMed ID: 17908708
[TBL] [Abstract][Full Text] [Related]
2. Statin use reduces decline in lung function: VA Normative Aging Study.
Alexeeff SE; Litonjua AA; Sparrow D; Vokonas PS; Schwartz J
Am J Respir Crit Care Med; 2007 Oct; 176(8):742-7. PubMed ID: 17673694
[TBL] [Abstract][Full Text] [Related]
3. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
Scanlon PD; Connett JE; Waller LA; Altose MD; Bailey WC; Buist AS; Tashkin DP;
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):381-90. PubMed ID: 10673175
[TBL] [Abstract][Full Text] [Related]
4. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
[TBL] [Abstract][Full Text] [Related]
5. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.
Kanner RE; Anthonisen NR; Connett JE;
Am J Respir Crit Care Med; 2001 Aug; 164(3):358-64. PubMed ID: 11500333
[TBL] [Abstract][Full Text] [Related]
6. In long-term smokers and former smokers the bronchodilator response is not related to the fall in FEV.
Stănescu D; Veriter C; Sanna A
Respiration; 1999; 66(6):501-5. PubMed ID: 10575334
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
Thomsen M; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
[TBL] [Abstract][Full Text] [Related]
8. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
9. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity.
Mohamed Hoesein FAA; Zanen P; Boezen HM; Groen HJM; van Ginneken B; de Jong PA; Postma DS; Lammers JJ
Chest; 2012 Dec; 142(6):1530-1538. PubMed ID: 22722231
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of PM10 pollution on pulmonary function of smokers with mild to moderate chronic obstructive pulmonary disease.
Pope CA; Kanner RE
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1336-40. PubMed ID: 8503541
[TBL] [Abstract][Full Text] [Related]
11. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies.
Sansores RH; Ramírez-Venegas A; Hernández-Zenteno R; Mayar-Maya ME; Pérez-Bautista OG; Velázquez Uncal M
Respir Med; 2013 Apr; 107(4):580-6. PubMed ID: 23313037
[TBL] [Abstract][Full Text] [Related]
13. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
14. Poor interpretation of pulmonary function tests in patients with concomitant decreases in FEV1 and FVC.
Hong Y; Ra SW; Shim TS; Lim CM; Koh Y; Lee SD; Kim WS; Kim DS; Kim WD; Oh YM
Respirology; 2008 Jun; 13(4):569-74. PubMed ID: 18410263
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
[TBL] [Abstract][Full Text] [Related]
16. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
17. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
18. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?
Hansen JE; Sun XG; Wasserman K
Eur Respir J; 2006 Jun; 27(6):1244-50. PubMed ID: 16455822
[TBL] [Abstract][Full Text] [Related]
19. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD.
Walters JA; Hansen EC; Johns DP; Blizzard EL; Walters EH; Wood-Baker R
Thorax; 2008 May; 63(5):408-14. PubMed ID: 18024537
[TBL] [Abstract][Full Text] [Related]
20. [The characteristics and clinical manifestation of subjects with non-specific pattern of pulmonary function tests].
Zhou DX; Wei JA; Chen Q; Gai J; Chen YW; Gao ZC
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):821-4. PubMed ID: 24507392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
